Company · CIK 0001764013 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Immunovant, Inc. · IMVT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 25, 4:05 pm EDT | Christopher Van TuylChief Legal Officer | 2,846 | $36.36 | $103,481 | 176,545 | −1.59% | |
| Aug 28, 2026 SForm 4 → | Aug 28, 4:27 pm EDT | Atul PandeDirector | 1,500 | $43.27 | $64,905 | 116,731 | −1.27% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 28, 4:27 pm EDT | Atul PandeDirector | 1,500 | $8.43 | $12,645 | 118,231 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 MForm 4 → | Aug 28, 4:27 pm EDT | Atul PandeDirector | 1,500 | — | — | 65,181 | — | 10b5-1 |